137 per cent returns from 52-week low: Company proposal to Establish New Branch in Raigad District, Maharashtra As Part of Business Expansion

The stock gave multibagger returns of 137 per cent from its 52-week low of Rs 870 per share.

Jeena Sikho Lifecare Limited proposes to establish a new 150-bed hospital branch in Raigad District, Maharashtra, specifically at Survey No. 62/1/B, Village Karnala, Taluka Panvel. This expansion, slated for commencement in July 2025, will occupy approximately 4.9 acres of leased property. The initiative is driven by the company's strategic objective to broaden its healthcare network and extend quality medical services to a wider population.

The project, requiring an estimated investment of Rs 6 crore, will be financed through the company's internal funds. This disclosure, made under Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and SEBI Circular SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, highlights the proposed capacity addition of 150 beds, where the existing capacity.

Jeena Sikho Lifecare has established itself as a significant ayurvedic healthcare provider in India, with a decade of service. They offer a diverse range of Ayurvedic products and actively engage in public health initiatives, conducting free health checkup camps and yoga sessions to promote wellness awareness.

The company's network comprises 119 clinics and hospitals, including specialized HIIMS and Shuddhi Panchakarma centers, enabling them to deliver personalized treatments and distribute over 300 products. Notably, 17 of their facilities, including both HIIMS and Shuddhi Panchakarma centers, have achieved NABH accreditation, signifying their commitment to quality healthcare standards.

The shares of the company have an ROE of 43 per cent and an ROCE of 58 per cent. The stock gave multibagger returns of 137 per cent from its 52-week low of Rs 870 per share. Investors should keep an eye on this stock.

Disclaimer: The article is for informational purposes only and not investment advice.